This nuclear energy stock has more than tripled over the past year. HSBC sees more gains ahead

The key incremental signal is not the coverage initiation itself, but that Oklo is moving from a pure story stock toward a quasi-policy-enabled industrial platform. The federal pilot framework materially lowers the probability of a prolonged permitting deadlock, which should compress the discount rate investors apply to first revenue and subsequent site replication. That matters because in pre-scale nuclear, the market is valuing execution optionality more than current earnings; any credible path to repeatable licensing can re-rate the entire small modular reactor peer set.

Second-order beneficiaries are less obvious: domestic nuclear fuel services, specialty fabrication, and radiochemistry vendors gain from a policy regime that favors localized supply chains. By contrast, utilities and independent power producers pursuing conventional baseload buildouts may face a higher hurdle rate if capital starts rotating toward “approved” advanced nuclear projects with federal validation. Meta is also indirectly signaled as a more committed buyer of firm power, which supports the broader data-center power procurement trade and could lift other behind-the-meter nuclear or geothermal concepts.

The main risk is that the stock is already pricing a lot of execution. The gap between pilot approval and commercial-scale deployment is still measured in years, and any slippage on criticality, cost overruns, or financing terms would hit hard because the equity is effectively a long-duration call option on regulatory success. Near term, the catalyst stack is binary: first revenue later this year, milestone updates into mid-2026, and any additional federal funding or loan support over the next 6-18 months.

Consensus looks directionally right but may be underestimating how much of the upside depends on capital structure rather than reactor physics. If financing remains mostly equity-funded, dilution could cap returns even with good operational progress; if debt and customer prepayments scale, the stock can keep compounding. The market may also be underpricing the chance that federal support creates a winner-take-most dynamic in advanced nuclear, leaving lagging peers stranded without comparable policy access.